Christopher M. Lindblom
Geen lopende functies
Loopbaan van Christopher M. Lindblom
Eerdere bekende functies van Christopher M. Lindblom
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25-04-2016 | 25-07-2016 |
| Treasurer | 25-07-2016 | 01-10-2016 | |
| DNIB UNWIND INC | Hoofd Administratief Officier | 01-03-2014 | 21-03-2016 |
| Financieel Directeur/CFO | 01-03-2014 | 21-03-2016 | |
| Bedrijfssecretaris | 01-03-2014 | 21-03-2016 | |
| Treasurer | 01-03-2014 | 21-03-2016 | |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-01-2006 | 12-04-2013 |
| Corporate Officer/Principal | 12-04-2013 | - | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Financieel Directeur/CFO | 07-06-2013 | 07-06-2013 |
| Corporate Officer/Principal | 07-06-2013 | 19-06-2013 | |
| Treasurer | 19-06-2013 | - |
Opleiding van Christopher M. Lindblom
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Treasurer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
